Table 7.

Percentage (%) of improvement in MG-ADL and QMG by patient type and symptom subdomain (sd) * Kruskal-Wallis non-parametric test.

	Prevalent ocular patients			p	Prevalent bulbar patients			p	Prevalent generalizated patients			p
% improvement MG-ADL		59.6 (31)				50.11 (40)				61.02 (48)		0.89*
	Ocular signs	Bulbar signs	Generalized signs		Ocular signs	Bulbar signs	Generalized signs		Ocular signs	Bulbar signs	Generalized signs
	55 (33)	39 (31)	66 (28)	0.74**	44 (48)	49 (33)	57 (31)	0.67**	39 (53)	66 (41)	65 (44)	0.39**

	Prevalent ocular patients			p	Prevalent bulbar patients			p	Prevalent generalizated patients			p
% improvement QMG		13.42 (19)				37.44 (20)				28.32 (51)		0.03*
	Ocular signs	Bulbar signs	Generalized signs		Ocular signs	Bulbar signs	Generalized signs		Ocular signs	Bulbar signs	Generalized signs
	44 (22)	45 (27)	5 (13)	0.01**	32 (15)	46 (32)	39 (22)	0.45**	59 (41)	78 (76)	66 (37)	0.34**

** U-Mann–Whitney test for independent samples.